Gender violence and schooling, Associated factors and barriers that hinder the timely detection of cervical cancer in Hidalgo, Mexico
DOI:
https://doi.org/10.19230/jonnpr.2513Keywords:
Cervical cancer, possessive / aggressive, restrictive character, cervical cytologyAbstract
Cervical cancer (CCU), or cancer of the cervix, is the most common carcinoma in women worldwide; is the malignancy that occurs regularly in the cervical epithelium, so it requires periodic analysis.
Aim. To determine the impact of gender violence and level of schooling, as well as factors and barriers that interfere in the timely detection of cervical cancer.
Methodology. An observational cross-sectional and analytic study was conducted on 384 women from the La Providencia and Bosques del Peñar neighborhoods in Pachuca Hidalgo, Mexico. through a structured survey with prior consent.
Results. 12% of women report having a restrictive partner, 23% frequently bother with her, 16% have a possessive partner and 11% have a low level of education. The number of women who underwent the cervical cytology examination once a year were (52%), 11% are performed twice a year, 12% are not performed regularly. The restrictive behavior of the couple is associated with variables such as the level of schooling, with the frequency of attendance at cervical cytology and fundamentally, level of schooling with Couple / Possessive, obtaining the following OR value: 1.66 (p <0.05) and Level of schooling with cervical cytology, with an OR: 1.32. with (p <0.05).
Conclusions. School attendance and attendance at the gynecology service, as well as the restrictive / possessive, possessive / aggressive nature of the couple represent barriers that are associated and interfere in the timely detection of cervical cancer.
Downloads
References
Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992; 69 (11):2796-806
Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17 (5): 1339-48
Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high- risk cervical cancer. N Engl J Med 1999;340 (15): 1137-43
Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340 (15): 1144-53
Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and
adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340 (15): 1154-61
Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18 (8):1606-13
Thomas GM: Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. N Engl J Med 1999; 340 (15): 1198-200
Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26 (35): 5802- 12
Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20 (4): 966-72
Rose PG, Bundy BN: Chemoradiation for locally advanced cervical cancer: does it help? J Clin Oncol 2002; 20 (4): 891-3
Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007; 25 (20): 2952-65
Patel FD, Sharma SC, Negi PS, et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1994; 28 (2): 335-41
Hareyama M, Sakata K, Oouchi A, et al. High-dose-rate versus low- dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial. Cancer 2002; 94 (1): 117-24
Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys. 2004; 59 (5): 1424- 31
Nag S, Chao C, Erickson B, et al. The American Brachytherapy Society
recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002; 52 (1): 33-48
Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48 (1): 201-11
Ruvalcaba Ledezma JC, Cortés Ascencio SY, Jiménez Mora JM. Salud pública en México implicaciones para la enseñanza de la biología y las ciencias de la salud. Biografía: escritos sobre la enseñanza de la biología ISSN: 2027-1034, 2013; 6(10): 51-58
Cortés Ascencio SY. y Ruvalcaba Ledezma JC. La corresponsabilidad en Salud Pública. Viva Salud para todos. 2011; 1 41-43.
Cortés Ascencio Sandra Yazmín, Jesús Carlos Ruvalcaba Ledezma, Avila Domínguez
Rosangela, Torres Guevara Rosa Silvana, Calderón Rodríguez Nelly Patricia, Pérez
Torres Lucia Vanessa, Barragán López Norma, Cobián Díaz Mariela Lizbeth, and
Reynoso Vázquez Josefina, “Co-responsibility and Intercultural in Public Health.”
American Journal of Public Health Research, 2017. vol. 5, (6): 174-180. DOI:
12691/ajphr-5-6-2
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
